Finance Watch: VC Round Extensions Attractive While Stock Market Wobbles
2022 Ended With Just 22 Biopharma IPOs
Private Company Edition: While Coya Therapeutics raised $15.25m in the final initial public offering in the US last year, Apnimed stayed private raising $80m in a series C extension and Metagenomi extended its series B by $100m to total $275m.
